These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7606630)

  • 1. High factor-VII activity in the elderly is related to vascular disease through activation of the coagulation system.
    Kario K; Matsuo T
    J Cardiovasc Risk; 1994 Aug; 1(2):165-71. PubMed ID: 7606630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of lipoprotein (a) in patients suffering from myocardial infarction with carotid atherosclerotic lesions.
    Avellone G; Di Garbo V; Abruzzese G; Campisi D; Giannola G; De Simone R; Raneli G
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):331-9. PubMed ID: 10493214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of continuous venovenous hemofiltration on coagulation activation.
    Bouman CS; de Pont AC; Meijers JC; Bakhtiari K; Roem D; Zeerleder S; Wolbink G; Korevaar JC; Levi M; de Jonge E
    Crit Care; 2006; 10(5):R150. PubMed ID: 17069648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K; Matsuo T
    Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
    Cachrimanidou AC; Hellberg D; Nilsson S; von Schoulz B; Crona N; Siegbahn A
    Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function.
    Adams MJ; Irish AB; Watts GF; Oostryck R; Dogra GK
    Thromb Res; 2008; 123(2):374-80. PubMed ID: 18486198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences of disturbed hemostasis related to fasting insulin level in healthy very elderly Japanese aged > or = 75 years.
    Kario K; Matsuo T; Kobayashi H; Sakata T; Miyata T; Shimada K
    Atherosclerosis; 1995 Aug; 116(2):211-9. PubMed ID: 7575776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial triglycerides and blood coagulation.
    Silveira A
    Exp Clin Endocrinol Diabetes; 2001; 109(4):S527-32. PubMed ID: 11453040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese.
    Kario K; Matsuo T; Kobayashi H; Asada R; Matsuo M
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):734-41. PubMed ID: 8640400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.
    Kario K; Matsuo T; Kobayashi H; Matsuo M; Sakata T; Miyata T
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1114-20. PubMed ID: 7627704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of coagulation/fibrinolysis genes: gene environment interactions and vascular risk.
    Grant PJ
    Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):473-7. PubMed ID: 9430399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence against an effect of endothelin-1 on blood coagulation, fibrinolysis, and endothelial cell integrity in healthy men.
    Kapiotis S; Jilma B; Szalay T; Dirnberger E; Wagner O; Eichler HG; Speiser W
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2861-7. PubMed ID: 9409267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
    Zitoun D; Bara L; Basdevant A; Samama MM
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
    Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.